2014/3/3 12:00
Conditions: Psychotic Disorders; Schizophrenia; Schizoaffective Disorder; Medication Adherence; Medication Non-Adherence
Intervention: Behavioral: CAE-L
Sponsor: University Hospitals of Cleveland
Not yet recruiting - verified March 2014
2014/2/25 12:00
Conditions: Schizophrenia; Schizoaffective Disorder
Intervention: Drug: Paliperidone ER
Sponsors: Taipei City Hospital; Johnson & Johnson Taiwan Ltd; Taipei Institute of Pathology
Completed - verified February 2014
2014/2/11 12:00
Conditions: Attention Deficit/Hyperactivity Disorder; Oppositional Defiant Disorder; Conduct Disorder
Interventions: Drug: Methylphenidate; Drug: Risperidone
Sponsor: Sheba Medical Center
Recruiting - verified February 2014
2014/1/14 12:00
Condition: Schizophrenia
Interventions: Drug: Risperidone/Olanzapine/Quetiapine/Ziprasidone/Aripiprazole; Drug: Tandospirone
Sponsors: Guangzhou Psychiatric Hospital; Qingyun Yin
Not yet recruiting - verified January 2014
2014/1/8 12:00
Conditions: Schizophrenia; Psychosis; First Episode Psychosis
Intervention: Drug: Risperidone
Sponsor: University of Alabama at Birmingham
Recruiting - verified January 2014
2013/12/18 12:00
Condition: Schizophrenia
Interventions: Drug: RO5545965; Drug: Placebo; Drug: risperidone
Sponsor: Hoffmann-La Roche
Not yet recruiting - verified December 2013
2013/12/10 12:00
Condition: Healthy
Interventions: Drug: Risperdal OD Tab. 2mg; Drug: Risperdal Quicklet Tab. 2mg
Sponsor: Janssen Korea, Ltd., Korea
Completed - verified December 2013
2013/12/2 12:00
Condition: Schizophrenia
Intervention:
Sponsor: Sumitomo Pharmaceutical (Suzhou) Co., Ltd.
Not yet recruiting - verified December 2013
2013/10/22 12:00
Condition: Bipolar I Disorder
Interventions: Drug: Valproate; Drug: Lithium; Drug: Risperidone; Drug: Olanzapine; Other: Placebo
Sponsors: University of British Columbia; Canadian Institutes of Health Research (CIHR); Eli Lilly and Company; Janssen-Ortho Inc., Canada
Completed - verified October 2013
2013/9/17 12:00
Condition: Schizophrenia
Intervention: Drug: Paliperidone Palmitate
Sponsors: Xian-Janssen Pharmaceutical Ltd.; Xian-Janssen Pharmaceutical Ltd.
Not yet recruiting - verified September 2013
2013/9/10 12:00
Condition: Schizophrenia
Intervention: Drug: Paliperidone palmitate
Sponsors: Janssen Pharmaceutical K.K.; Janssen Pharmaceutical K.K.
Completed - verified September 2013
2013/8/19 12:00
Condition: Schizophrenia
Intervention: Drug: No intervention
Sponsors: Janssen-Cilag International NV; Janssen-Cilag International NV
Recruiting - verified August 2013
2013/7/29 12:00
Conditions: Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder
Interventions: Drug: Aripiprazole; Drug: Risperidone; Drug: Modafinil
Sponsors: University of California, San Francisco; University of California, San Francisco; The Dana Foundation
Recruiting - verified July 2013
2013/7/3 12:00
Condition: Schizophrenia
Interventions: Drug: Risperidone; Drug: Oral atypical anti-psychotic
Sponsors: Xian-Janssen Pharmaceutical Ltd.; Xian-Janssen Pharmaceutical Ltd.
Terminated - verified July 2013
2013/7/1 12:00
Condition: Treatment Resistant Depression
Interventions: Other: IPT+ antidepressant drugs; Drug: fluoxetine; Drug: sertraline; Drug: paroxetine; Drug: Citalopram; Drug: escitalopram; Drug: fluvoxamine; Drug: Venlafaxine; Drug: Duloxetine; Drug: Bupropion; Drug: Lithium; Drug: Risperidone; Drug: tranylcypromine; Drug: Imipramine; Drug: amitriptyline; Drug: Clomipramine; Drug: nortriptyline; Drug: trazodone; Drug: Mirtazapine; Drug: sulpiride
Sponsors: Hospital de Clinicas de Porto Alegre; Hospital de Clinicas de Porto Alegre
Recruiting - verified July 2013
2013/1/18 12:00
Condition: Schizophrenia
Intervention: Drug: No intervention
Sponsors: Janssen Korea, Ltd., Korea; Janssen Korea, Ltd., Korea
Active, not recruiting - verified July 2013
2013/1/14 12:00
Conditions: Schizophrenia; Schizophreniform Disorder; Schizoaffective Disorder
Interventions: Drug: Risperidone; Drug: Omega-3 capsules; Drug: Amber 50/50 Soybean/Corn Placebo
Sponsors: North Shore Long Island Jewish Health System; Delbert Robinson; National Institute of Mental Health (NIMH); National Alliance for Research on Schizophrenia and Depression
Recruiting - verified July 2013
2012/11/9 12:00
Condition: Schizophrenia
Intervention: Drug: Risperidone prolonged release
Sponsors: Janssen-Cilag Ltd.; Janssen-Cilag Ltd.
Completed - verified July 2013
2012/9/13 12:00
Conditions: Schizophrenia; Schizoaffective Disorder
Intervention:
Sponsors: Massachusetts General Hospital; David C. Henderson; Novartis Pharmaceuticals
Recruiting - verified July 2013
2012/9/6 12:00
Condition: Schizophrenia
Intervention: Drug: Paliperidone palmitate
Sponsors: Janssen Korea, Ltd., Korea; Janssen Korea, Ltd., Korea
Active, not recruiting - verified July 2013